The head of the public health services, Dr. Sharon Elrai Price, said today (Tuesday) here 11: "We have a lot of tests and we are not able to reach them all.
I do not know exactly what the number of verified is every day, I guess between 40,000 and 50,000. "
She added: "We are in very large numbers and it is impossible for a doctor to release everyone. It is clear that when you make shortcuts there is a chance that a person who infects is taken out. Once we have changed the guidelines and there is a variant that infects quickly, it is clear to me
On Sheba's research on the fourth vaccine, she said: "There was no mistake in vaccinating the population over the age of 60 with the fourth vaccine. I know from the media. "
It is important to note that "Israel Today" has learned that the director general of the Ministry of Health, Prof. Nachman Ash, was updated before the results were published in the media.
Prof. Nachman Ash // Photo: Eyal Margolin - Ginny,
Asked whether in light of Sheba's research results, the Health Rebellion would decide not to extend the fourth dose to the general population, she replied: "Even now we do not expand. "The vaccine on Wednesday is effective, so maybe we will decide to expand it to the entire population."
On the question of whether the decision to shorten the isolation days to five, she said: "There are decisions that are policy, not everything is a net professional vision, need balances."
On what Prof. Idit Matot said, she said: "We are not at war with her. We are all in this epidemic together and there is a lot of pressure. It is allowed to criticize and disagree with our choices. We must check and isolate, we can not lock the population at risk. The head is in the sand. "
Prof. Idit Matot // Photo: Miri Gatnio - Spokeswoman at Ichilov Hospital,
Prof. Gili Regev Yohai, director of the Infection Prevention and Control Unit at Sheba Hospital, tells Israel Today in an interview with the findings of the fourth vaccine trial:
She added: "We are two weeks after 154 people received a fourth dose of Pfizer, and a week after a fourth dose of modern research. Pfizer's dose raised antibodies quite nicely. We saw an increase after a week, and another small increase after two weeks to a level slightly higher than that. Which we saw after the third vaccine, but it is not enough for the omicron.
"The decision to give the vaccine to vulnerable people was probably the right one. It gives a little advantage, but not enough to give the vaccine to the whole population."
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us
